Timothy Rolph, DPhil
2022
In 2022, Timothy Rolph, DPhil earned a total compensation of $4.2M as Chief Scientific Officer at Akero Therapeutics, a 135% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $337,400 |
|---|---|
| Option Awards | $2,556,818 |
| Salary | $482,000 |
| Stock Awards | $824,425 |
| Total | $4,200,643 |
DPhil received $2.6M in option awards, accounting for 61% of the total pay in 2022.
DPhil also received $337.4K in non-equity incentive plan, $482K in salary and $824.4K in stock awards.
Rankings
In 2022, Timothy Rolph, DPhil's compensation ranked 812th out of 5,744 executives tracked by ExecPay. In other words, DPhil earned more than 85.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 812 out of 5,744 | 86th |
Division Manufacturing | 371 out of 3,128 | 88th |
Major group Chemicals And Allied Products | 126 out of 1,416 | 91st |
Industry group Drugs | 113 out of 1,317 | 91st |
Industry Pharmaceutical Preparations | 84 out of 963 | 91st |
Pay ratio
| Timothy Rolph, DPhil's Pay | $4,200,643 |
|---|---|
| Median Employee's Pay | $515,516 |
| Pay Ratio | 8to 1 |
In 2022, the annual total compensation of Timothy Rolph, DPhil was $4,200,643.
The annual total compensation of the median employee at Akero Therapeutics was $515,516.
The ratio of Timothy Rolph, DPhil's pay to the pay of median employee was therefore 8 to one.
Source: SEC filing on April 28, 2023.
DPhil's colleagues
We found four more compensation records of executives who worked with Timothy Rolph, DPhil at Akero Therapeutics in 2022.